- Home
- CIVI vs SRRK Comparison
CIVI vs SRRK Comparison
Compare CIVI & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CIVI | SRRK |
|---|---|---|
| Founded | 1999 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 4.6B |
| IPO Year | 2011 | 2018 |
Fundamental Metrics
Financial Performance| Metric | CIVI | SRRK |
|---|---|---|
| Price | $27.45 | $43.76 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 13 | 9 |
| Target Price | $40.80 | ★ $47.88 |
| AVG Volume (30 Days) | ★ 1.4M | 1.3M |
| Earning Date | 11-06-2025 | 11-14-2025 |
| Dividend Yield | ★ 7.34% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 6.86 | N/A |
| Revenue | ★ $4,711,808,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $20,271.77 |
| P/E Ratio | $3.97 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $22.79 | $22.71 |
| 52 Week High | $55.35 | $48.28 |
Technical Indicators
Market Signals| Indicator | CIVI | SRRK |
|---|---|---|
| Relative Strength Index (RSI) | 45.25 | 52.78 |
| Support Level | $26.51 | $42.61 |
| Resistance Level | $28.28 | $46.14 |
| Average True Range (ATR) | 0.91 | 1.88 |
| MACD | -0.14 | -0.47 |
| Stochastic Oscillator | 25.83 | 16.97 |
Price Performance
Historical ComparisonAbout CIVI Civitas Resources Inc.
Civitas Resources Inc is an independent exploration and production company engaged in the acquisition, development, and production of oil and associated liquids-rich natural gas in the Rocky Mountain region, in the Denver-Julesburg Basin of Colorado - DJ Basin. The company's operations are focused on developing the horizontal Niobrara and Codell formations that have a low-cost structure, mature infrastructure, production efficiencies, multiple producing horizons, multiple service providers, established reserves, and prospective drilling opportunities.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.